NCT00412529 - Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

February 29, 2008

Conditions

Hepatitis BChronic Hepatitis B

Interventions

DRUG

Entecavir

Entecavir 0.5 mg once daily for 12 weeks.

DRUG

Telbivudine

Telbivudine 600 mg once daily for 12 weeks.

Trial Locations (8)

Holy Family Hospital_Bucheon, Bucheon,Kyunggi

Inje University Busan Paik Hospital, Busan

Yeungnam University Medical Center, Daegu

Gachon Univ. Gil Medical Center Hospital, Incheon

Asan Medical Center, Seoul

Kangnam Sacred Heart Hospital, Seoul

Korea University Medical Center_Anam, Seoul

The Catholic University of Korea, Seoul